252 related articles for article (PubMed ID: 6714369)
1. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
[TBL] [Abstract][Full Text] [Related]
2. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
Vargaftig BB; Joseph D; Marlas G; Chevance LG
Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
[TBL] [Abstract][Full Text] [Related]
3. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
Wal F; Joseph D; Touqui L; Vargaftig BB
Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
[TBL] [Abstract][Full Text] [Related]
4. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
Adnot S; Joseph D; Vargaftig BB
Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
[TBL] [Abstract][Full Text] [Related]
5. Convulxin-induced activation of intact and of thrombin-degranulated rabbit platelets: specific crossed desensitisation with collagen.
Vargaftig BB; Joseph D; Wal F; Marlas G; Chignard M; Chevance LG
Eur J Pharmacol; 1983 Aug; 92(1-2):57-68. PubMed ID: 6628537
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
7. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
[TBL] [Abstract][Full Text] [Related]
8. Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets.
Coëffier E; Ninio E; Le Couedic JP; Chignard M
Br J Haematol; 1986 Apr; 62(4):641-51. PubMed ID: 3964558
[TBL] [Abstract][Full Text] [Related]
9. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
[TBL] [Abstract][Full Text] [Related]
10. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
11. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
Touqui L; Jacquemin C; Vargaftig BB
Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
[TBL] [Abstract][Full Text] [Related]
12. Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine.
Chignard M; Le Couedic JP; Coëffier E; Benveniste J
Biochem Biophys Res Commun; 1984 Oct; 124(2):637-43. PubMed ID: 6437404
[TBL] [Abstract][Full Text] [Related]
13. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.
Benveniste J; Chignard M; Le Couedic JP; Vargaftig BB
Thromb Res; 1982 Mar; 25(5):375-85. PubMed ID: 6803388
[TBL] [Abstract][Full Text] [Related]
16. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.
Fouque F; Joseph D; Vargaftig BB
Agents Actions; 1982 Dec; 12(5-6):720-2. PubMed ID: 7164947
[TBL] [Abstract][Full Text] [Related]
18. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
Simon MF; Chap H; Braquet P; Douste-Blazy L
Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518
[TBL] [Abstract][Full Text] [Related]
19. 3 Deazaadenosine and L-homocysteine inhibit platelet aggregation induced by collagen and convulxin through a phospholipase A2 independent mechanism.
Randon J; Chignard M; Marlas G; Vargaftig BB
Thromb Res; 1982 Oct; 28(2):269-74. PubMed ID: 6817456
[No Abstract] [Full Text] [Related]
20. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]